Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2010 - 2026)

Pacific Biosciences Of California's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $48.2 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 57.47% year-over-year to $48.2 million in Q1 2026; TTM through Mar 2026 was $274.9 million, a 2158.87% increase from a year earlier, with the FY2025 full-year figure at $340.1 million, up 875.65% from the prior year.
• Change in Acquisitions & Divestments fell to $48.2 million in Q1 2026 per PACB's latest filing, from $60.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $320.1 million in Q3 2023 and bottomed at -$445.6 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $128.8 million (2024), against an average of $91.7 million.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 422.26% in 2024 and soared 113.46% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $138.3 million in 2023, then tumbled by 422.26% to -$445.6 million in 2024, then soared by 113.46% to $60.0 million in 2025, then declined by 19.56% to $48.2 million in 2026.
• Per Business Quant, the three latest PACB Change in Acquisitions & Divestments figures stand at $48.2 million (Q1 2026), $60.0 million (Q4 2025), and $84.6 million (Q3 2025).